0001628280-24-008968.txt : 20240305
0001628280-24-008968.hdr.sgml : 20240305
20240305164927
ACCESSION NUMBER: 0001628280-24-008968
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240304
FILED AS OF DATE: 20240305
DATE AS OF CHANGE: 20240305
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Farid Ramy
CENTRAL INDEX KEY: 0001797707
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39206
FILM NUMBER: 24721626
MAIL ADDRESS:
STREET 1: SCHRODINGER, INC.
STREET 2: 120 WEST 45TH STREET, 17TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Schrodinger, Inc.
CENTRAL INDEX KEY: 0001490978
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 954284541
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1540 BROADWAY
STREET 2: 24TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
BUSINESS PHONE: 503-299-1150
MAIL ADDRESS:
STREET 1: 1540 BROADWAY
STREET 2: 24TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
4
1
wk-form4_1709675347.xml
FORM 4
X0508
4
2024-03-04
0
0001490978
Schrodinger, Inc.
SDGR
0001797707
Farid Ramy
C/O SCHRODINGER, INC.,
1540 BROADWAY, 24TH FLOOR
NEW YORK
NY
10036
1
1
0
0
President & CEO
0
Stock Option (right to buy)
25.24
2024-03-04
4
A
0
126000
0
A
2034-03-04
Common Stock
126000
126000
D
Stock Option (right to buy)
27.76
2024-03-04
4
A
0
87271
0
A
2034-03-04
Common Stock
87271
87271
D
The option was granted on March 4, 2024. The shares underlying the option are scheduled to vest with respect to 25% of the shares on March 4, 2025 and the remainder are scheduled to vest in equal monthly installments through March 4, 2028.
The option was granted on March 4, 2024. The exercise price per share is equal to 110% of the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant. The shares underlying the option are scheduled to vest with respect to 25% of the shares on March 4, 2025 and the remainder are scheduled to vest in equal monthly installments through March 4, 2028.
/s/ Donald Shum, as attorney-in-fact for Ramy Farid
2024-03-05